GlobeNewswire 11/15/2011 Premier Cercle : 2nd COMPETITION SUMMIT highlights new ways for Antitrust in Brussels

GlobeNewswire 8/11/2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised

GlobeNewswire 6/1/2011 Evotec acquires compound management business from Galapagos

GlobeNewswire 3/7/2011 Changes to composition Heineken Holding N.V.'s Board of Directors

GlobeNewswire 2/10/2011 Otto Drakenberg appointed new CEO of Arcus-Gruppen

GlobeNewswire 12/22/2010 Victor Duran appointed Amer Sports Executive Board member

GlobeNewswire 9/24/2010 Novartis sells US rights to the overactive bladder treatment Enablex®

GlobeNewswire 4/6/2010 XCHANGING WINS PROCUREMENT OUTSOURCING CONTRACT WITH CHEP EUROPE TO MANAGE A TOTAL SPEND OF £375 MIL...

GlobeNewswire 3/16/2010 Notice of Annual General Meeting of Hakon Invest AB (publ)

GlobeNewswire 12/22/2009 HEIKKI TAKALA HAS BEEN APPOINTED PRESIDENT AND CEO OF AMER SPORTS CORPORATION

GlobeNewswire 12/21/2009 Edvantage group signs strategic agreement with Saba

GlobeNewswire 1/20/2009 ABLYNX EXPANDS ITS MUSCULOSKELETAL PORTFOLIO BY TAKING P&G PHARMACEUTICALS' PROGRAMME IN-HOUSE

GlobeNewswire 11/5/2008 Cisco Reports First Quarter Earnings

GlobeNewswire 8/15/2008 Rorento N.V. Annual Report 2007

GlobeNewswire 4/11/2008 Study shows once-yearly Aclasta® better than risedronate at increasing bone mass in patients with os...

GlobeNewswire 6/18/2007 ABLYNX IDENTIFIES NOVEL NANOBODIES® ACHIEVING SECOND MILESTONE IN PROCTER & GAMBLE COLLABORATION

GlobeNewswire 7/25/2005 Procter & Gamble Selects Evotec as Provider of Pharmaceutical Discovery and Chemical Development Ser...

GlobeNewswire 7/6/2005 Novartis and Procter & Gamble enter into commercialization agreement for Enablex®

GlobeNewswire 6/11/2003 Galapagos Genomics and Procter & Gamble Collaborate in Osteoporosis